Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intervention Study Focused on the Intestinal Microbiome to Evaluate the Impact of a Wild Thyme Extract (Thymus Serpyllum) Extract With Anti-inflammatory and Metabolic Properties Against Functional Gastrointestinal Disorders.

NCT06639126 is registered in ClinicalTrials.gov with Fundación Pública Andaluza para la Investigación Biomédica Andalucía Oriental as lead sponsor.

NCT NCT06639126
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06639126 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intervention Study Focused on the Intestinal Microbiome to Evaluate the Impact of a Wild Thyme Extract (Thymus Serpyllum) Extract With Anti-inflammatory and Metabolic Properties Against Functional Gastrointestinal Disorders.
Lead sponsor
Fundación Pública Andaluza para la Investigación Biomédica Andalucía Oriental
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
February 1, 2024
Completion date
April 30, 2025
Enrollment
75 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

functional gastrointestinal disorders